Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Tricaprilin in Mild to Moderate Alzheimer's Disease

ClinicalTrials.gov ID: NCT00142805

Public ClinicalTrials.gov record NCT00142805. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 3:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety, Tolerability and Efficacy Study of Tricaprilin (AC-1202) Administered for Ninety Days in Subjects With Probable Alzheimer's Disease of Mild to Moderate Severity

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety, tolerability and effectiveness of tricaprilin administered once a day for ninety days in subjects with mild to moderate, probable Alzheimer's disease.

Study identification

NCT ID
NCT00142805
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Cerecin
Industry
Enrollment
152 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
50 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 4, 2004 (Actual)
Primary completion
Jun 29, 2006 (Actual)
Completion
Jan 7, 2007 (Actual)
Last update posted
Sep 21, 2020

2004 – 2007

United States locations

U.S. sites
25
U.S. states
7
U.S. cities
23
Facility City State ZIP Site status
21st Century Neurology, a division of Xenoscience Inc. Phoenix Arizona 85013 —
Comprehensive NeuroScience Cerritos California 90703 —
Pharmacology Research Institute Los Alamitos California 90720 —
Pharmacology Research Institute Newport Beach California 92660 —
Pharmacology Research Institute Northridge California 91324 —
The Southwest Institute for Clinical Research Rancho Mirage California 92270 —
Pharmacology Research Institute Riverside California 92506 —
Baumel-Eisner Neuromedical Institute Boca Raton Florida 33486 —
Meridien Research Brooksville Florida 34613 —
Baumel-Eisner Neuromedical Institute, Inc. Fort Lauderdale Florida 33321 —
Sunrise Clinical Research Hollywood Florida 33021 —
Comprehensive NeuroScience Melbourne Florida 32935 —
Baumel-Eisner Neuromedical Institute Miami Beach Florida 33154 —
Anchor Research Center Naples Florida 34102 —
Renstar Medical Research Ocala Florida 34471 —
Comprehensive NeuroScience St. Petersburg Florida 33702 —
Meridien Research St. Petersburg Florida 33709 —
Meridien Research Tampa Florida 33609 —
Radiant Research Chicago Illinois 60610 —
Multi-Specialty Research Associates of North Carolina Raleigh North Carolina 27609 —
Radiant Research Portland Oregon 97239 —
Radiant Research Dallas Texas 75231 —
Research Across America Dallas Texas 75234 —
Radiant Research San Antonio Texas 78229 —
Grayline Clinical Drug Trials Wichita Falls Texas 76309 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00142805, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 21, 2020 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00142805 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →